neurotensin [Ligand Id: 1579] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL407196 (Neurotensin)
  • NTS1 receptor/Neurotensin receptor 1 in Human [ChEMBL: CHEMBL4123] [GtoPdb: 309] [UniProtKB: P30989]
  • NTS1 receptor/Neurotensin receptor 1 in Mouse [ChEMBL: CHEMBL3570] [GtoPdb: 309] [UniProtKB: O88319]
  • NTS1 receptor/Neurotensin receptor 1 in Rat [ChEMBL: CHEMBL3027] [GtoPdb: 309] [UniProtKB: P20789]
There should be some charts here, you may need to enable JavaScript!
  • NTS2 receptor/Neurotensin receptor 2 in Human [ChEMBL: CHEMBL2514] [GtoPdb: 310] [UniProtKB: O95665]
  • NTS2 receptor in Mouse [GtoPdb: 310] [UniProtKB: P70310]
  • NTS2 receptor/Neurotensin receptor 2 in Rat [ChEMBL: CHEMBL5106] [GtoPdb: 310] [UniProtKB: Q63384]
There should be some charts here, you may need to enable JavaScript!
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
NTS1 receptor/Neurotensin receptor 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4123] [GtoPdb: 309] [UniProtKB: P30989]
ChEMBL Displacement of [3H]neurotensin from human NTS1 receptor expressed in CHO cells B 9.23 pKd 0.59 nM Kd J. Med. Chem. (2011) 54: 2915-2923 [PMID:21446649]
ChEMBL Displacement of [3H]neurotensin from human NTS1 receptor expressed in CHO cells B 9.29 pKd 0.51 nM Kd J. Med. Chem. (2013) 56: 9361-9365 [PMID:24160350]
ChEMBL Displacement of [3H]NT(8-13) from wild type human NTR1 expressed in HEK293 cells B 8.68 pKi 2.1 nM Ki Bioorg. Med. Chem. (2008) 16: 9359-9368 [PMID:18809332]
ChEMBL Displacement of [125I]I-Tyr(3)NT from human NTR1 B 8.79 pKi 1.64 nM Ki J. Med. Chem. (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Displacement of radiolabeled neurotensin from human neurotensin receptor 1 B 8.82 pKi 1.5 nM Ki J. Med. Chem. (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL Binding affinity to human NTS1 receptor by radioligand displacement assay B 9.57 pKi 0.27 nM Ki Eur. J. Med. Chem. (2013) 63: 85-94 [PMID:23466604]
GtoPdb - - 9.7 pKi - - - Mol. Pharmacol. (2001) 60: 1392-8 [PMID:11723247];
Biochem. Pharmacol. (2000) 60: 793-801 [PMID:10930533]
ChEMBL Antagonist activity at human NTS1 receptor expressed in CHOK1 cells assessed as inhibition of intracellular calcium elevation pretreated 30 mins before with SR-48692 by FLIPR assay F 8.22 pIC50 6.03 nM IC50 Bioorg. Med. Chem. Lett. (2008) 18: 5789-5789 [PMID:18849166]
ChEMBL Displacement of [125I]I-Tyr(3)NT from human NTR1 B 8.66 pIC50 2.19 nM IC50 J. Med. Chem. (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Displacement of radiolabeled neurotensin from human neurotensin receptor 1 B 8.74 pIC50 1.8 nM IC50 J. Med. Chem. (2008) 51: 7094-7098 [PMID:18983139]
ChEMBL Inhibition of human NTS1 receptor B 8.85 pIC50 1.4 nM IC50 J. Med. Chem. (2008) 51: 4150-4169 [PMID:18588282]
ChEMBL Displacement of [125I]Tyr3-NT from human NTS1R expressed in HT29 cells B 9.21 pIC50 0.62 nM IC50 J. Med. Chem. (2006) 49: 4767-4776 [PMID:16854083]
ChEMBL Displacement of [125I]Tyr3-neurotensin from human recombinant NTS1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method B 9.31 pIC50 0.49 nM IC50 Bioorg Med Chem (2017) 25: 471-482 [PMID:27876250]
ChEMBL Displacement of [125I]Tyr3-neurotensin from human recombinant NT1 receptor expressed in CHO cells B 9.31 pIC50 0.49 nM IC50 Bioorg. Med. Chem. (2016) 24: 1793-1810 [PMID:26988801]
ChEMBL Displacement of [125I]Tyr3-NT from human NTS1R expressed in WiDr cells B 9.34 pIC50 0.46 nM IC50 J. Med. Chem. (2006) 49: 4767-4776 [PMID:16854083]
ChEMBL Binding affinity to human NTS1 receptor by radioligand displacement assay B 9.48 pIC50 0.33 nM IC50 Eur. J. Med. Chem. (2013) 63: 85-94 [PMID:23466604]
ChEMBL Binding affinity to NTS1 receptor (unknown origin) by radioligand displacement assay B 9.62 pIC50 0.24 nM IC50 Bioorg. Med. Chem. (2013) 21: 2764-2771 [PMID:23582449]
ChEMBL Binding affinity towards neurotensin receptor in membranes prepared from HT-29 cell line, relative to [111In]-labeled neurotensin peptide B 9.7 pIC50 0.2 nM IC50 J. Med. Chem. (2003) 46: 3403-3411 [PMID:12852770]
ChEMBL Agonist activity at human NTS1 receptor expressed in CHOK1 cells assessed as increase in intracellular calcium level by FLIPR assay F 6.51 pEC50 310 nM EC50 Bioorg. Med. Chem. Lett. (2008) 18: 5789-5789 [PMID:18849166]
ChEMBL Agonist activity at human NTR1 assessed as increase in intracellular calcium concentration F 8.7 pEC50 2 nM EC50 J. Med. Chem. (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Agonist activity at NTR1 in human HT-29 cells assessed as increase in intracellular calcium concentration by FLIPR assay F 8.7 pEC50 1.98 nM EC50 J. Med. Chem. (2009) 52: 1803-1813 [PMID:19290594]
ChEMBL Agonist activity at human NTS1 receptor expressed in HEK293 cells assessed as inhibition of constitutive activity on MAPK-mediated luciferase activity F 8.8 pEC50 1.6 nM EC50 J. Med. Chem. (2011) 54: 2915-2923 [PMID:21446649]
ChEMBL Agonist activity at NTR1 expressed in CHOK1 cells by calcium mobilization assay F 9.64 pEC50 0.23 nM EC50 Bioorg. Med. Chem. Lett. (2009) 19: 1438-1441 [PMID:19195889]
NTS1 receptor/Neurotensin receptor 1 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3570] [GtoPdb: 309] [UniProtKB: O88319]
ChEMBL Concentration producing half maximal inhibition of specific binding of [125I]-Tyr3-NT(1-13) to NT receptor in neonatal mouse whole brain (minus cerebellum) B 9.77 pKi 0.17 nM Ki Bioorg. Med. Chem. Lett. (1993) 3: 949-952
ChEMBL Agonist activity at NTR1 in mouse N1E-115 cells assessed as increase in intracellular calcium concentration F 8.7 pEC50 2 nM EC50 J. Med. Chem. (2009) 52: 1803-1813 [PMID:19290594]
NTS1 receptor/Neurotensin receptor 1 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3027] [GtoPdb: 309] [UniProtKB: P20789]
ChEMBL Displacement of [125L]NT from rat neurotensin receptor type 1 expressed in CHOK1 cells by radioligand binding assay B 8.77 pKi 1.7 nM Ki Bioorg. Med. Chem. Lett. (2015) 25: 292-296 [PMID:25499438]
ChEMBL Displacement of [125I]neurotensin from rat NTS1 receptor expressed in CHO-K1 cells by competitive binding assay B 8.96 pKi 1.1 nM Ki J. Med. Chem. (2014) 57: 7472-7477 [PMID:25157640]
GtoPdb - - 10 pKi - - - Mol. Pharmacol. (2003) 64: 421-9 [PMID:12869647];
Biochem. Pharmacol. (2000) 60: 793-801 [PMID:10930533];
J. Biol. Chem. (1998) 273: 16351-7 [PMID:9632698]
ChEMBL Agonist activity at rat NTS1 stably expressed in CHOK1 cells assessed as induction of calcium release by FLIPR assay F 10.4 pEC50 0.04 nM EC50 J. Med. Chem. (2014) 57: 5318-5332 [PMID:24856674]
NTS2 receptor/Neurotensin receptor 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2514] [GtoPdb: 310] [UniProtKB: O95665]
ChEMBL Displacement of [3H]NT from human NTS2 receptor expressed in HEK293 cells B 8.31 pKi 4.9 nM Ki J. Med. Chem. (2011) 54: 2915-2923 [PMID:21446649]
ChEMBL Displacement of [3H]NT(8 to 13) from human NTS2 receptor expressed in HEK293 cells B 8.31 pKi 4.9 nM Ki J. Med. Chem. (2013) 56: 9361-9365 [PMID:24160350]
GtoPdb - - 8.8 pKi - - - Mol. Pharmacol. (2001) 60: 1392-8 [PMID:11723247]
ChEMBL Agonist activity at human NTS2 receptor expressed in HEK293 cells assessed as inhibition of constitutive activity on MAPK-mediated luciferase activity F 6.96 pEC50 110 nM EC50 J. Med. Chem. (2011) 54: 2915-2923 [PMID:21446649]
NTS2 receptor in Mouse [GtoPdb: 310] [UniProtKB: P70310]
GtoPdb - - 8.7 pIC50 - - - Biochem. Biophys. Res. Commun. (1998) 243: 585-90 [PMID:9480852]
NTS2 receptor/Neurotensin receptor 2 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5106] [GtoPdb: 310] [UniProtKB: Q63384]
ChEMBL Displacement of [125I]neurotensin from rat NTS2 receptor expressed in CHO-K1 cells by competitive binding assay B 7.55 pKi 28 nM Ki J. Med. Chem. (2014) 57: 7472-7477 [PMID:25157640]
ChEMBL Displacement of [125L]NT from rat neurotensin receptor type 2 expressed in CHOK1 cells by radioligand binding assay B 7.68 pKi 21 nM Ki Bioorg. Med. Chem. Lett. (2015) 25: 292-296 [PMID:25499438]
ChEMBL Displacement of [125I]NT at rat NTS2 overexpressed in CHOK1 cells after 30 mins by gamma counting B 7.72 pKi 18.9 nM Ki J. Med. Chem. (2014) 57: 5318-5332 [PMID:24856674]
ChEMBL Antagonist activity at rat NTS2 receptor expressed in CHO-K1 cells assessed as inhibition of SR142948a-induced calcium mobilization by FLIPR assay F 6.94 pIC50 114 nM IC50 J. Med. Chem. (2014) 57: 7472-7477 [PMID:25157640]
ChEMBL Antagonist activity at rat neurotensin receptor type 2 expressed in CHOK1 cells assessed as inhibition of SR142948a-induced calcium release by FLIPR assay F 7.38 pIC50 42 nM IC50 Bioorg. Med. Chem. Lett. (2015) 25: 292-296 [PMID:25499438]
ChEMBL Antagonist activity at rat NTS2 stably expressed in CHOK1 cells assessed as inhibition of SR142948a-induced calcium release by FLIPR assay F 7.73 pIC50 18.5 nM IC50 J. Med. Chem. (2014) 57: 5318-5332 [PMID:24856674]
GtoPdb - - 8.2 pIC50 - - - J. Biol. Chem. (1999) 274: 13752-9 [PMID:10318778]
ChEMBL Agonist activity at rat neurotensin receptor type 2 expressed in CHOK1 cells assessed as increase in calcium release by FLIPR assay F 7 pEC50 >100 nM EC50 Bioorg. Med. Chem. Lett. (2015) 25: 292-296 [PMID:25499438]
Neurotensin receptor 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3091] [UniProtKB: Q99523]
ChEMBL Displacement of [3H]-neurotensin from human sortilin incubated 30 mins prior to [3H]-neurotensin addition measured after 6 hrs by scintillation proximity assay B 6.44 pIC50 360 nM IC50 Bioorg. Med. Chem. Lett. (2014) 24: 177-180 [PMID:24355129]

ChEMBL data shown on this page come from version 26:

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, CibriƔn-Uhalte E, Davies M, Dedman N, Karlsson A, MagariƱos MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]